Physician
Lind, Peter
Lind, Peter was paid $479K by Medicaid between Jan 2020 and Mar 2023, across 23 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 23% of everything it billed.
33Billing provider infoLIND, PETER
FALMOUTH, MA 02540
FALMOUTH, MA 02540
33aNPI1396782009assigned 06/01/2006
33bProvider typePediatrics Physician
28Total paid$479K
24GClaims11,026
24DCodes billed23
24AFirst – last monthJan 2020 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#155 of 1,273
Median peer was paid$24K
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,463 | $92K | |
| 2021 | 4,121 | $184K | |
| 2022 | 3,898 | $179K | |
| 2023 | 544 | $24K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 1,037 | 991 | $110K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 1,787 | 1,666 | $104K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 13% | 1,200 | 1,168 | $61K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9.2% | 1,166 | 1,164 | $44K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 8.3% | 555 | 548 | $40K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.4% | 194 | 194 | $17K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.2% | 1,489 | 1,487 | $15K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.1% | 180 | 180 | $15K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.0% | 156 | 156 | $14K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.9% | 1,514 | 1,513 | $14K |
| 90461 | 2.7% | 356 | 356 | $13K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.4% | 489 | 481 | $12K |
11 more codes
| 87634 | 1.5% | 236 | $7K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 213 | $4K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 43 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 45 | $1K |
| 0072A | <1% | 29 | $1K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 15 | $1K |
| 0071A | <1% | 12 | $550.56 | |
| 94760 | <1% | 255 | $502.92 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 30 | $366.30 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 13 | $158.99 |
| 99177 | <1% | 12 | $44.64 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.